Belvedere Trading
KZR

Belvedere Trading’s Kezar Life Sciences KZR Stock Holding History

Belvedere Trading’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,727
Closed -$152K – 472
2022
Q1 		$252K Buy
+1,727
New +$248K 0.01% 205

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Belvedere Trading's KZR Position: Q2 2022 in Review

Belvedere Trading sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 1,727 shares — an estimated $152K sold.

Belvedere Trading first reported a position in KZR in Q1 2022 and held it in 1 quarter. The position peaked at $252K in Q1 2022. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

  • Belvedere Trading reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 1,727 Kezar Life Sciences shares in Q2 2022, an estimated $152K.
  • Belvedere Trading first reported a position in Kezar Life Sciences in Q1 2022 and held it in 1 quarter.
  • Belvedere Trading's Kezar Life Sciences position peaked at $252K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.